304 related articles for article (PubMed ID: 23931795)
21. Malignant transformation in IgM monoclonal gammopathy of undetermined significance.
Montoto S; Rozman M; Rosiñol L; Nadal E; Giné E; Aymerich M; Ferrer A; Esteve J; Bosch F; López-Guillermo A; Bladé J; Montserrat E
Semin Oncol; 2003 Apr; 30(2):178-81. PubMed ID: 12720132
[TBL] [Abstract][Full Text] [Related]
22. IgA monoclonal gammopathy of undetermined significance with peripheral neuropathy.
Mehndiratta MM; Sen K; Tatke M; Bajaj BK
J Neurol Sci; 2004 Jun; 221(1-2):99-104. PubMed ID: 15178222
[TBL] [Abstract][Full Text] [Related]
23. Monoclonal gammopathy of undetermined significance.
Kyle RA; Rajkumar SV
Clin Lymphoma Myeloma; 2005 Sep; 6(2):102-14. PubMed ID: 16231848
[TBL] [Abstract][Full Text] [Related]
24. Review of peripheral neuropathy in plasma cell disorders.
Silberman J; Lonial S
Hematol Oncol; 2008 Jun; 26(2):55-65. PubMed ID: 18324611
[TBL] [Abstract][Full Text] [Related]
25. Clinical, electrophysiological and immunological study of peripheral nerves in Egyptian patients with monoclonal gammopathies.
El-Difrawy MM; Zaki NE; Marouf HM; Ayad MW; Farag AM
Int J Hematol; 2012 Jan; 95(1):71-6. PubMed ID: 22193843
[TBL] [Abstract][Full Text] [Related]
26. Diagnostic framing of IgM monoclonal gammopathy: Focus on Waldenström macroglobulinemia.
Tedeschi A; Conticello C; Rizzi R; Benevolo G; Laurenti L; Petrucci MT; Zaja F; Varettoni M
Hematol Oncol; 2019 Apr; 37(2):117-128. PubMed ID: 30192023
[TBL] [Abstract][Full Text] [Related]
27. Anti-sulfatide IgM antibodies in peripheral neuropathy: to test or not to test?
Giannotta C; Di Pietro D; Gallia F; Nobile-Orazio E
Eur J Neurol; 2015 May; 22(5):879-82. PubMed ID: 25597226
[TBL] [Abstract][Full Text] [Related]
28. [Diagnostic value of autoantibodies to MAG by ELISA Bühlmann in 117 immune-mediated peripheral neuropathies associated with monoclonal IgM to SGPG/SGLPG].
Caudie C; Kaygisiz F; Jaquet P; Petiot P; Gonnaud PM; Antoine JC; Vial C
Ann Biol Clin (Paris); 2006; 64(4):353-9. PubMed ID: 16829480
[TBL] [Abstract][Full Text] [Related]
29. [Detection of antibodies binding to myelin in 75 neuropathies associated with IgM gammopathy].
Campant RM; Caudie C; Kopp N; Lombard C; Later R
Ann Biol Clin (Paris); 1999; 57(1):69-75. PubMed ID: 9920969
[TBL] [Abstract][Full Text] [Related]
30. IgM monoclonal gammopathy-associated neuropathies with different IgM specificity.
Matà S; Borsini W; Ambrosini S; Toscani L; Barilaro A; Piacentini S; Sorbi S; Lolli F
Eur J Neurol; 2011 Aug; 18(8):1067-73. PubMed ID: 21261794
[TBL] [Abstract][Full Text] [Related]
31. Pathogenesis and therapy of neuropathies associated with monoclonal gammopathies.
Latov N
Ann Neurol; 1995 May; 37 Suppl 1():S32-42. PubMed ID: 8968215
[TBL] [Abstract][Full Text] [Related]
32. Treatment of immune-mediated, dysimmune neuropathies.
Finsterer J
Acta Neurol Scand; 2005 Aug; 112(2):115-25. PubMed ID: 16008538
[TBL] [Abstract][Full Text] [Related]
33. Diagnostic criteria of multiple myeloma.
Kyle RA
Hematol Oncol Clin North Am; 1992 Apr; 6(2):347-58. PubMed ID: 1582977
[TBL] [Abstract][Full Text] [Related]
34. [Dysglobulinemic neuropathies].
Gherardi R; Zuber M; Viard JP
Rev Neurol (Paris); 1988; 144(6-7):391-408. PubMed ID: 2847276
[TBL] [Abstract][Full Text] [Related]
35. IgM monoclonal gammopathy of undetermined significance (MGUS) and smoldering Waldenström's macroglobulinemia (SWM).
Kyle RA; Dispenzieri A; Kumar S; Larson D; Therneau T; Rajkumar SV
Clin Lymphoma Myeloma Leuk; 2011 Feb; 11(1):74-6. PubMed ID: 21454195
[TBL] [Abstract][Full Text] [Related]
36. Multiple autoimmune manifestations in monoclonal gammopathy of undetermined significance and chronic lymphocytic leukemia.
Jønsson V; Svendsen B; Vorstrup S; Krarup C; Schmalbruch H; Thomsen K; Heegaard NH; Wiik A; Hansen MM
Leukemia; 1996 Feb; 10(2):327-32. PubMed ID: 8637242
[TBL] [Abstract][Full Text] [Related]
37. Neurologic aspects of plasma cell disorders.
Sobol U; Stiff P
Handb Clin Neurol; 2014; 120():1083-99. PubMed ID: 24365373
[TBL] [Abstract][Full Text] [Related]
38. [Acquired peripheral neuropathies associated with monoclonal gammopathy].
Gajos A; Kieliś W; Szadkowska I; Chmielowska E; Niewodniczy A; Bogucki A
Neurol Neurochir Pol; 2007; 41(2):169-75. PubMed ID: 17530580
[TBL] [Abstract][Full Text] [Related]
39. Advances in the Treatment of Paraproteinemic Neuropathy.
Nobile-Orazio E; Bianco M; Nozza A
Curr Treat Options Neurol; 2017 Oct; 19(12):43. PubMed ID: 29034435
[TBL] [Abstract][Full Text] [Related]
40. Peripheral neuropathy in monoclonal gammopathy of undetermined significance: prevalence and immunopathogenetic studies.
Nobile-Orazio E; Barbieri S; Baldini L; Marmiroli P; Carpo M; Premoselli S; Manfredini E; Scarlato G
Acta Neurol Scand; 1992 Jun; 85(6):383-90. PubMed ID: 1379409
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
